Just three weeks after medical oncologist Leonard Saltz, epidemiologist Peter Bach, and Physician-in-Chief Robert Wittes authored an opinion piece on Memorial Sloan-Kettering’s decision not to carry a new colorectal cancer drug due to its cost, the pharmaceutical company said it would cut the price of the drug in half.
Pediatric neurosurgeon Mark Souweidane spoke about a phase I clinical trial for children with diffuse intrinsic pontine glioma, a type of brain stem cancer.
Music therapist Karen Popkin was interviewed about her job as Director of the Music Therapy program at Memorial Sloan-Kettering and music’s healing properties.
Oncology nurse Kim Goldfine joined several other nurses from the Westchester area to discuss the challenges and rewards of their profession, what they wish people knew about nursing care, and what patients can do to ensure the best outcome from a hospital stay.
Radiation oncologist Michael Zelefsky discussed a study he led that found that prostate cancer patients who received oral erectile medication before and after their radiation therapy had improved sexual function.
Medical oncologist Andrew Epstein commented on a study that found that a majority of patients with advanced cancer believe the chemotherapy they are receiving will cure their disease when it likely will not.
Epidemiologist Pär Stattin talked about a study he led that found that men with metabolic syndrome may also face a higher risk of dying from prostate cancer if diagnosed with the disease.
Memorial Sloan-Kettering’s Joe Licata and one of the center’s most frequent platelet donors were interviewed about Memorial Sloan-Kettering’s ongoing need for more blood donors and why blood and platelets are so important for cancer patients’ health.
Integrative Medicine Service Chief Barrie Cassileth was interviewed about complementary therapies such as acupuncture, massage, and yoga for cancer patients. Massage therapist Jane Greene, acupuncturist Yi Chan, and T'ai Chi instructor Yang Yang were also filmed with patients in both the inpatient and outpatient settings.
Thoracic oncologist Mark Kris spoke about the collaboration between Memorial Sloan-Kettering and IBM to develop a powerful cancer resource, built on the IBM Watson system, to provide medical professionals with improved access to current and comprehensive cancer data and practices.
Clinical psychologist Talia Zaider talked about the emotional distress some men experience as a result of sexual dysfunction related to prostate cancer treatment.
Medical oncologist Leonard Saltz, epidemiologist Peter Bach, and Physician-in-Chief Robert Wittes authored an opinion piece on Memorial Sloan-Kettering’s decision not to carry a new colorectal cancer drug due to its cost. They argue that the drug is no better than other, less expensive options.
Good Morning America co-host Robin Roberts said good-bye to her Memorial Sloan-Kettering inpatient treatment team, after being hospitalized for several weeks and receiving a stem cell transplant for the treatment of myelodysplastic syndrome. Chief of Memorial Sloan-Kettering’s Adult Bone Marrow Transplant ServiceSergio Giralt is directing Ms. Roberts’s care.
Radiologist Carol Lee spoke about the benefits and risks of 3-D mammography, or tomosynthesis. Dr. Lee also discussed the technology in the Washington Post and the Morning Call.
Director of Memorial Sloan-Kettering's Adult Long-Term Follow-Up ProgramKevin Oeffinger discussed a study that found that more young adult cancer survivors are likely to go without medical care because of cost than peers who have not had cancer.
